(Q53184665)
Statements
Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study. (English)
Kimberly J Chin
1 March 2012
28
2
85-89
scientific article published in March 2012